Cigarette smoking in the U.S. is highest among low income and Medicaid insured adults, and
unfortunately, low-income smokers are even less likely to attempt to quit, less likely to use
evidence-based treatments, and thus less likely to be successful. Federally Qualified Health
Centers (FQHCs), which generally provide healthcare services to low income and Medicaid
insured patients, are more likely to serve individuals who use tobacco and are required to
report tobacco use screening rates and their delivery of cessation interventions. Thus, FQHCs
are an ideal community-partner to reach low-income smokers, particularly smokers who are not
currently seeking treatment. To address this gap, the investigators developed a
pharmacist-delivered smoking cessation intervention to help facilitate nicotine replacement
therapy medication adherence among smokers. The proposed study aims to examine the
feasibility of delivering the pharmacist-delivered smoking cessation intervention to FQHC
patients who are ready to quit, and expanding the intervention for smokers not ready to quit
by adding 2 pre-quit sessions focused on rate reduction. The investigators will also
determine facilitators and barriers to adopting and implementing the program in FQHCs.